Back to User profile » Dr Michael C. Mosier

Papers published by Dr Michael C. Mosier:

Original Research

Crossover safety study of aprepitant: 2-min injection vs 30-min infusion in cancer patients receiving emetogenic chemotherapy

Navari RM, Mosier MC

OncoTargets and Therapy 2019, 12:3277-3284

Published Date: 30 April 2019

Original Research

APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide–based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial

Schnadig ID, Agajanian R, Dakhil C, Gabrail N, Vacirca J, Taylor C, Wilks S, Braun E, Mosier MC, Geller RB, Schwartzberg L, Vogelzang N

Cancer Management and Research 2017, 9:179-187

Published Date: 19 May 2017